Associated Papers
GLP1R (glucagon-like-peptide-1 incretin receptor), diabetes and obesity phenotypes: An in silico approach revealed new pathogenic variants.
Knihs VM et al.
Diabetes & Metabolic Syndrome, 2024
Rare Heterozygous Loss-of-Function Variants in the Human GLP-1 Receptor Are Not Associated With Cardiometabolic Phenotypes.
Melchiorsen JU et al.
The Journal of Clinical Endocrinology and Metabolism, 2023
GWAS of random glucose in 476,326 individuals provide insights into diabetes pathophysiology, complications and treatment stratification.
Lagou V et al.
Nature Genetics, 2023
37679419 (PubMed )
Supplement: 41588_2023_1462_MOESM6_ESM.xlsx › SuppTable12
Select a paper to view details